This was the stock's sixth consecutive day of losses.

Labcorp will acquire the oncology diagnostics operations from BioReference Health as part of a push to expand in high-growth ...

The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.

Truist analyst David MacDonald notes Labcorp (LH) announced that the company has reached an agreement to acquire oncology-focused lab testing assets from BioReference Health (OPK) for $192.5M, with an ...

Labcorp (LH) and OPKO Health (OPK) announced earlier on Tuesday that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...

Labcorp Holdings has signed a deal to buy certain assets of OPKO Health's BioReference Health unit for up to $225 million. Labcorp on Tuesday said it will pay $192.5 million at closing for ...

The sale comes after the Miami company agreed to pay $704,349 to settle allegations that it billed the federal government for ...

Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.

A Durham company with a slumping stock is implementing changes to its board after reaching a deal with an activist investor.

In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Labcorp Holdings (LH – Research Report), with a ...

Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...